2022
DOI: 10.1016/j.apsb.2022.04.014
|View full text |Cite
|
Sign up to set email alerts
|

Overcoming Mycobacterium tuberculosis through small molecule inhibitors to break down cell wall synthesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 99 publications
(105 reference statements)
0
10
0
Order By: Relevance
“…Atypical among bacteria, it has an elaborate dense multilayered structure, devoid of the majority of transporters, that helps to protect it against the actions of the host immune cells, adverse environments, and many antimicrobial agents. It is thus not surprising that various inhibitors of specific processes of the cell wall biosynthesis [ 8 , 9 , 10 , 11 ] have long been established as a major group of antitubercular drugs. Moreover, the approaches aiming to directly target and modulate the mycobacterial membranes are currently seen as very promising [ 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…Atypical among bacteria, it has an elaborate dense multilayered structure, devoid of the majority of transporters, that helps to protect it against the actions of the host immune cells, adverse environments, and many antimicrobial agents. It is thus not surprising that various inhibitors of specific processes of the cell wall biosynthesis [ 8 , 9 , 10 , 11 ] have long been established as a major group of antitubercular drugs. Moreover, the approaches aiming to directly target and modulate the mycobacterial membranes are currently seen as very promising [ 12 ].…”
Section: Introductionmentioning
confidence: 99%
“…Numerous studies suggest that the pathogenesis and durability of mycolic acids depend on the functional groups in their acyl chains [50]. The 1KPI proteins various metabolic activities are inhibited by a few nitrogen containing heterocyclic drug molecules [51]. Hence, we chosen the 1KPI protein for docking studies with the synthesized compounds.…”
Section: Methodsmentioning
confidence: 99%
“…The EmbC is a transmembrane protein that plays a crucial role in extending the arabinan chains in AG and LAM 13 . Ethambutol (EMB), a first-line anti-tuberculosis drug, can mediate the addition of arabinose units to the growing polysaccharide chains, thereby determining the length and structure of the arabinan 14 . Inhibition of arabinan synthesis eliminates the mycolic acid anchoring site, causing a reduction in the accumulation of mycolic acids in the cell wall.…”
Section: Introductionmentioning
confidence: 99%